A Phase 3B, Open Label, Randomized, Standard-Of-Care Control Arm, Mult
Research payments
$2,249,439
Through program year 2025, $2,249,439 in research payments was reported against A Phase 3B, Open Label, Randomized, Standard-Of-Care Control Arm, Mult, across 426 payments, paid by ViiV Healthcare Company.
- Paid by
- ViiV Healthcare Company
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $2,249,425 | 425 |
| 2024 | Research | $14 | 1 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Robert Grossberg Bronx, NY Named on 36 payments
- Cornelius Van Dam Greensboro, NC Named on 33 payments
- Ethel Weld Largo, MD Named on 22 payments
- Mobeen Rathore Jacksonville, FL Named on 22 payments
- Onyema Ogbuagu New Haven, CT Named on 21 payments
- Thomas Campbell Aurora, CO Named on 20 payments
- Harold Katner Macon, GA Named on 15 payments
- Manuel Pardo West Hollywood, CA Named on 15 payments
- Sonya Heath Birmingham, AL Named on 15 payments
- Hector Bolivar Miami, FL Named on 14 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.